These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 27495357)
1. To what extent is it possible to dissociate the anxiolytic and sedative/hypnotic properties of GABAA receptors modulators? Chagraoui A; Skiba M; Thuillez C; Thibaut F Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():189-202. PubMed ID: 27495357 [TBL] [Abstract][Full Text] [Related]
2. A Pharmacogenetic 'Restriction-of-Function' Approach Reveals Evidence for Anxiolytic-Like Actions Mediated by α5-Containing GABAA Receptors in Mice. Behlke LM; Foster RA; Liu J; Benke D; Benham RS; Nathanson AJ; Yee BK; Zeilhofer HU; Engin E; Rudolph U Neuropsychopharmacology; 2016 Sep; 41(10):2492-501. PubMed ID: 27067130 [TBL] [Abstract][Full Text] [Related]
3. Involvement of the GABA Mattei C; Taly A; Soualah Z; Saulais O; Henrion D; Guérineau NC; Verleye M; Legros C Pharmacol Res; 2019 Jul; 145():104250. PubMed ID: 31059790 [TBL] [Abstract][Full Text] [Related]
4. The GABAA-BZR complex as target for the development of anxiolytic drugs. Trincavelli ML; Da Pozzo E; Daniele S; Martini C Curr Top Med Chem; 2012; 12(4):254-69. PubMed ID: 22204488 [TBL] [Abstract][Full Text] [Related]
5. Attaining in vivo selectivity of positive modulation of α3βγ2 GABA Batinić B; Stanković T; Stephen MR; Kodali R; Tiruveedhula VV; Li G; Scholze P; Marković BD; Obradović AL; Ernst M; Cook JM; Savić MM Eur Neuropsychopharmacol; 2018 Aug; 28(8):903-914. PubMed ID: 29891214 [TBL] [Abstract][Full Text] [Related]
6. Anxioselective compounds acting at the GABA(A) receptor benzodiazepine binding site. Atack JR Curr Drug Targets CNS Neurol Disord; 2003 Aug; 2(4):213-32. PubMed ID: 12871032 [TBL] [Abstract][Full Text] [Related]
8. Are GABAA receptors containing alpha5 subunits contributing to the sedative properties of benzodiazepine site agonists? Savić MM; Huang S; Furtmüller R; Clayton T; Huck S; Obradović DI; Ugresić ND; Sieghart W; Bokonjić DR; Cook JM Neuropsychopharmacology; 2008 Jan; 33(2):332-9. PubMed ID: 17392731 [TBL] [Abstract][Full Text] [Related]
9. Selective antagonism of GABAA receptor subtypes: an in vivo approach to exploring the therapeutic and side effects of benzodiazepine-type drugs. Rowlett JK; Cook JM; Duke AN; Platt DM CNS Spectr; 2005 Jan; 10(1):40-8. PubMed ID: 15618946 [TBL] [Abstract][Full Text] [Related]
10. Development of subtype selective GABAA modulators. Dawson GR; Collinson N; Atack JR CNS Spectr; 2005 Jan; 10(1):21-7. PubMed ID: 15618944 [TBL] [Abstract][Full Text] [Related]
11. Benzodiazepine-induced anxiolysis and reduction of conditioned fear are mediated by distinct GABAA receptor subtypes in mice. Smith KS; Engin E; Meloni EG; Rudolph U Neuropharmacology; 2012 Aug; 63(2):250-8. PubMed ID: 22465203 [TBL] [Abstract][Full Text] [Related]
12. Both alpha2 and alpha3 GABAA receptor subtypes mediate the anxiolytic properties of benzodiazepine site ligands in the conditioned emotional response paradigm. Morris HV; Dawson GR; Reynolds DS; Atack JR; Stephens DN Eur J Neurosci; 2006 May; 23(9):2495-504. PubMed ID: 16706856 [TBL] [Abstract][Full Text] [Related]
13. Lotus Leaf Alkaloid Extract Displays Sedative-Hypnotic and Anxiolytic Effects through GABAA Receptor. Yan MZ; Chang Q; Zhong Y; Xiao BX; Feng L; Cao FR; Pan RL; Zhang ZS; Liao YH; Liu XM J Agric Food Chem; 2015 Oct; 63(42):9277-85. PubMed ID: 26448283 [TBL] [Abstract][Full Text] [Related]
14. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. McKernan RM; Rosahl TW; Reynolds DS; Sur C; Wafford KA; Atack JR; Farrar S; Myers J; Cook G; Ferris P; Garrett L; Bristow L; Marshall G; Macaulay A; Brown N; Howell O; Moore KW; Carling RW; Street LJ; Castro JL; Ragan CI; Dawson GR; Whiting PJ Nat Neurosci; 2000 Jun; 3(6):587-92. PubMed ID: 10816315 [TBL] [Abstract][Full Text] [Related]
15. Flavan-3-ol derivatives are positive modulators of GABA(A) receptors with higher efficacy for the alpha(2) subtype and anxiolytic action in mice. Fernandez SP; Mewett KN; Hanrahan JR; Chebib M; Johnston GA Neuropharmacology; 2008 Oct; 55(5):900-7. PubMed ID: 18657554 [TBL] [Abstract][Full Text] [Related]
16. Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives. Auta J; Kadriu B; Giusti P; Costa E; Guidotti A Pharmacol Biochem Behav; 2010 Jun; 95(4):383-9. PubMed ID: 20227434 [TBL] [Abstract][Full Text] [Related]
17. GABAA receptor gamma 2 subunit knockdown mice have enhanced anxiety-like behavior but unaltered hypnotic response to benzodiazepines. Chandra D; Korpi ER; Miralles CP; De Blas AL; Homanics GE BMC Neurosci; 2005 Apr; 6():30. PubMed ID: 15850489 [TBL] [Abstract][Full Text] [Related]
18. GABAA/benzodiazepine receptor complex mediates the anxiolytic-like effect of Montanoa tomentosa. Sollozo-Dupont I; Estrada-Camarena E; Carro-Juárez M; López-Rubalcava C J Ethnopharmacol; 2015 Mar; 162():278-86. PubMed ID: 25582489 [TBL] [Abstract][Full Text] [Related]
19. Contribution of GABAA receptor subtypes to the anxiolytic-like, motor, and discriminative stimulus effects of benzodiazepines: studies with the functionally selective ligand SL651498 [6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyridol[3,4-b]indol-1-one]. Licata SC; Platt DM; Cook JM; Sarma PV; Griebel G; Rowlett JK J Pharmacol Exp Ther; 2005 Jun; 313(3):1118-25. PubMed ID: 15687371 [TBL] [Abstract][Full Text] [Related]
20. Flavonoid compounds isolated from Tibetan herbs, binding to GABA Liu Z; Silva J; Shao AS; Liang J; Wallner M; Shao XM; Li M; Olsen RW J Ethnopharmacol; 2021 Mar; 267():113630. PubMed ID: 33246118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]